Kristine Mørch, MD, PhD er leder ved Nationalt senter for tropiske infeksjonssykdommer ved infeksjonsseksjonen, medisinsk avdeling, Haukeland universitetssykehus. Hun er også førsteamanuensis ved klinisk institutt ved Universitetet i Bergen. Hennes forskningsinteresser er innenfor tropiske infeksjonssykdommer, spesielt akutt febersykdom og malaria, samt Giardia infeksjon med fokus på metronidazolresistens og behandling.

Doktorgradsavhandling

• Christel Gill Haanshuus; Stein Christian Mohn; Kristine Mørch et al. (2019). PCR based Malaria diagnostics : – Method development and application. (ekstern lenke)
• Kristine Mørch (2010). Giardiasis : with emphasis on treatment and post-infectious manifestations. (ekstern lenke)

Fagartikkel

• Eli Leirdal Hoem; Torleiv Kvalvik; Ruben Dyrhovden et al. (2024). En kvinne i 70-årene med feber og krampeanfall. (ekstern lenke)

Fremhevet artikkel i media

• Trond Engjom; Kristoffer Brodwall; Hilde Marie Engjom et al. (2013). Utveksling av helsepersonell mellom Bergen og Zanzibar. (ekstern lenke)

Konferanseabstrakt

• Karolina Rembeck; Magnus Lindh; Court Pedersen et al. (2012). Impact of Inosine Triphosphatase (ITPA) Gene Variants on Anemia, Ribavirin Concentrations, and Outcome During Therapy for HCV Genotype 2/3. (ekstern lenke)
• Magdalena Ydreborg; Martin Lagging; Gunnar P. Norkrans et al. (2012). A novel fibrosis index comprising a non-cholesterol sterol accurately predicts HCV-related liver cirrhosis. (ekstern lenke)
• Karolina Rembeck; Asa Alsio; Peer B. Christensen et al. (2011). Impact of obesity on the bioavailability of peginterferon-alpha 2A and ribavirin and treatment outcome for chronic hepatitis C genotype 2 or 3. (ekstern lenke)
• Asa Alsio; Nina Langeland; Court Pedersen et al. (2010). IMPORTANCE OF HCV CORE ANTIGEN BELOW 0.2 PG/ML DAY 3 IN SHORT-TERM PEG-INTERFERON THERAPY FOR CHRONIC GENOTYPE2/3 INFECTION. (ekstern lenke)
• Peter Derek Christian Leutscher; Mads Rauning Buhl; Martin Lagging et al. (2009). EVALUATION OF THE ROUTINE MEDICAL INTERVIEW TO IDENTIFY HEPATITIS C PATIENTS DEVELOPING MAJOR DEPRESSION DURING PEGINTERFERON ALFA-2A PLUS RIBAVIRIN TREATMENT USING THE MAJOR DEPRESSION INVENTORY. (ekstern lenke)
• Johan Westin; Martin Lagging; Carsten Pedersen et al. (2008). Twelve weeks of treatment is insufficient for HCV genotype 2 and 3 infected patients with steatosis. (ekstern lenke)
• Peer B. Christensen; Åsa Alsiö; Mads Rauning Buhl et al. (2008). Ribavirin concentration at week four is an independend predictor for sustained virological response after treatment of hepatitis C genotype 2/3 (NORDynamic trial). (ekstern lenke)
• Martin Lagging; Carsten Pedersen; Mads Rauning Buhl et al. (2007). Comparison of peginterferon alpha-2a and ribavirin for 12 or 24 weeks in patients with HCV genotype 2/3: The nordynamic trial. (ekstern lenke)
• Martin Lagging; Court Pedersen; Mads Rauning Buhl et al. (2007). Peginterferon alfa-2a and ribavirin for 12 or 24 weeks in patients with HCV genotype 2/3: The nordynamic trial. (ekstern lenke)

Konferanseposter

• Tore Lier; Gottfried Greve; Frank Olav Pettersen et al. (2018). Schistosomiasis in Norwegian medical students. (ekstern lenke)

Lederartikkel

• Kristine Mørch (2022). Apekopper i Norge. (ekstern lenke)

Leserbrev

• Lucy Robertson; Kristoffer Tysnes; Kurt Hanevik et al. (2015). Hund som Giardia-kilde i Bergen i 2004 - barking up the wrong tree?. (ekstern lenke)
• Martin Lagging; Åsa Alsiö; Nina Langeland et al. (2011). Early determination of Hepatitis C virus RNA may help to decide the duration of therapy for chronic Hepatitis C virus genotype 2/3 infection. (ekstern lenke)
• Martin Lagging; Nina Langeland; Court Pedersen et al. (2008). Weight-adjusted dosing of ribavirin and importance of hepatitis C virus RNA below 1000 IU/mL by day 7 in short-term peginterferon therapy for chronic genotype 2/3 hepatitis C virus infection. (ekstern lenke)

Vitenskapelig artikkel

• Kristine Mørch; Peter Chiodini; Laura Nabarro et al. (2026). Nitroimidazole - albendazole combination therapy, quinacrine use, and risk factors in nitroimidazole-refractory giardiasis: a prospective multicentre observational study. (ekstern lenke)
• Trygve Kristiansen; Sabrina John Moyo; Joel Manyahi et al. (2026). Antimicrobial resistance in paediatric bloodstream infections in Tanzania: a longitudinal comparison of two cohort studies. (ekstern lenke)
• Tilman Lingscheid; Johannes Jochum; Pinkus Tober-Lau et al. (2025). Severe imported <i>Plasmodium falciparum</i> malaria with hyperparasitaemia: evaluation of determinants of critical disease in adult returning travellers. (ekstern lenke)
• Sabrina John Moyo; Joel Manyahi; Said Aboud et al. (2025). Extended-spectrum-β-lactamase-producing Gram-negative bacteria are associated with high mortality in children with bloodstream infections in Dar es Salaam, Tanzania. (ekstern lenke)
• Jahid Hasan Tipu; Kristine Mørch; Kurt Hanevik (2025). Visited India? Metronidazole may not cure your <i>Giardia</i> infection. (ekstern lenke)
• Bjørn Blomberg; Trond Bruun; Stina Jordal et al. (2024). Ein mann i 60-åra med livstrugande febersjukdom etter utanlandsreise. (ekstern lenke)
• Mogens Jensenius; Kristine Mørch; Sheraz Yakub et al. (2024). Alveolær ekinokokkose. (ekstern lenke)
• Annette Onken; Sabrina John Moyo; Mohammed Khamis Miraji et al. (2024). Predominance of multidrug-resistant Salmonella Typhi genotype 4.3.1 with low-level ciprofloxacin resistance in Zanzibar. (ekstern lenke)
• Kristine Mørch; Anand Manoharan; Sara Chandy et al. (2023). Clinical features and risk factors for death in acute undifferentiated fever: A prospective observational study in rural community hospitals in six states of India. (ekstern lenke)
• Annette Onken; Christel Gill Haanshuus; Mohammed Khamis Miraji et al. (2022). Malaria prevalence and performance of diagnostic tests among patients hospitalized with acute undifferentiated fever in Zanzibar. (ekstern lenke)
• Kurt Hanevik; Christina Skår Saghaug; Maren Aaland et al. (2022). No difference in serum levels of B-cell activating receptor and antibodies against cytolethal distending toxin B and flagellin in post-infectious irritable bowel syndrome and chronic fatigue syndrome after Giardia infection. (ekstern lenke)
• Knut Erik Emberland; Knut-Arne Wensaas; Sverre Litleskare et al. (2021). Antibiotics for gastroenteritis in general practice and out-of-hours services in Norway 2006-15. (ekstern lenke)
• Andreas Neumayr; Mirjam Schunk; Caroline Theunissen et al. (2021). Efficacy and Tolerability of Quinacrine Monotherapy and Albendazole Plus Chloroquine Combination Therapy in Nitroimidazole-Refractory Giardiasis: A TropNet Study. (ekstern lenke)
• Jesper Waldenström; Kristoffer Hellstrand; Johan Westin et al. (2021). Presence of interferon-λ 4, male gender, absent/mild steatosis and low viral load augment antibody levels to hepatitis C virus. (ekstern lenke)
• Trygve Kristiansen; Frank O. Pettersen; Tore Lier et al. (2021). Schistosomiasis hos norske studenter etter opphold i Afrika. (ekstern lenke)
• Karl Erik Muller; Bjørn Blomberg; Marit Gjerde Tellevik et al. (2021). Leishmaniasis i Norge. (ekstern lenke)
• Kristine Mørch; Kurt Hanevik (2020). Giardiasis treatment: an update with a focus on refractory disease. (ekstern lenke)
• Sabrina John Moyo; Joel Manyahi; Bjørn Blomberg et al. (2020). Bacteraemia, malaria, and case fatality among children hospitalized with fever in Dar es Salaam, Tanzania. (ekstern lenke)
• Christel Gill Haanshuus; Kristine Mørch (2020). Detection of remaining Plasmodium DNA and gametocytes during follow up after curative malaria treatment among returned travellers in Norway. (ekstern lenke)
• Jesper Waldenström; Kristina Nyström; Staffan Nilsson et al. (2020). The relation of 25-hydroxy vitamin D concentrations to liver histopathology, seasonality and baseline characteristics in chronic hepatitis C virus genotype 2 or 3 infection. (ekstern lenke)
• Christel Gill Haanshuus; Kristine Mørch; Bjørn Blomberg et al. (2019). Assessment of malaria real-time PCR methods and application with focus on lowlevel parasitaemia. (ekstern lenke)
• Bjørn Blomberg; Karl Erik Muller; Lars Helgeland et al. (2019). En mann i 80-årene med leddgikt og vedvarende feber. (ekstern lenke)
• Kurt Hanevik; Einar Klæboe Kristoffersen; Kristine Mørch et al. (2017). Giardia-specific cellular immune responses in post-giardiasis chronic fatigue syndrome. (ekstern lenke)
• Tilman Lingscheid; Florian Kurth; Jan Clerinx et al. (2017). Schistosomiasis in european travelers and migrants: Analysis of 14 years tropnet surveillance data. (ekstern lenke)
• Florian Kurth; Michel Develoux; Matthieu Mechain et al. (2017). Severe malaria in Europe: an 8-year multi-centre observational study. (ekstern lenke)
• Sara Chandy; Lokeshwaran Kirubanandhan; Priya Hemavathy et al. (2017). Serovar prevalence of leptospira in semirural India and the development of an igm-based indirect ELISA. (ekstern lenke)
• Kristine Mørch; Anand Manoharan; Sara Chandy et al. (2017). Acute undifferentiated fever in India: A multicentre study of aetiology and diagnostic accuracy. (ekstern lenke)
• Christel Gill Haanshuus; Sara Chandy; Anand Manoharan et al. (2016). A high malaria prevalence identified by PCR among patients with acute undifferentiated fever in India. (ekstern lenke)
• Jesper Waldenström; Martti A. Färkkilä; Karolina Rembeck et al. (2016). Short interferon and ribavirin treatment for HCV genotype 2 or 3 infection: NORDynamIC trial and real-life experience. (ekstern lenke)
• Knut-Arne Wensaas; Kurt Hanevik; Trygve Hausken et al. (2016). Postinfectious and sporadic functional gastrointestinal disorders have different prevalences and rates of overlap: results from a controlled cohort study 3 years after acute giardiasis. (ekstern lenke)
• Florian Kurth; Michel Develoux; Matthieu Mechain et al. (2015). Intravenous artesunate reduces parasite clearance time, duration of intensive care, and hospital treatment in patients with severe malaria in Europe: The TropNet severe malaria study. (ekstern lenke)
• Åsmund Heggheim; Bjørn Blomberg; Kristine Mørch (2015). Beredskap ved alvorlig malaria. (ekstern lenke)
• Kristine Mørch; Gunhild Holmaas; PS frolander et al. (2015). Severe human Babesia divergens infection in Norway. (ekstern lenke)
• Eli Ben-Chetrit; Tamar Lachish; Kristine Mørch et al. (2015). Schistosomiasis in pregnant travelers: A case series. (ekstern lenke)
• Kurt Hanevik; Knut-Arne Wensaas; Guri Rørtveit et al. (2014). Irritable bowel syndrome and chronic fatigue 6 years after Giardia infection: A controlled prospective cohort study. (ekstern lenke)
• Karolina Rembeck; Jesper Waldenström; Kristoffer Hellstrand et al. (2014). Variants of the inosine triphosphate pyrophosphatase gene are associated with reduced relapse risk following treatment for HCV genotype 2/3. (ekstern lenke)
• Magdalena Ydreborg; Vera Lisovskaja; Martin Lagging et al. (2014). A novel fibrosis index comprising a non-cholesterol sterol accurately predicts HCV-related liver cirrhosis. (ekstern lenke)
• Kristine Mørch; Kurt Hanevik; Ann Christin Rivenes et al. (2013). Chronic fatigue syndrome 5 years after giardiasis: differential diagnoses, characteristics and natural course. (ekstern lenke)
• Christel Gill Haanshuus; Stein Christian Mohn; Kristine Mørch et al. (2013). A novel, single-amplification PCR targeting mitochondrial genome highly sensitive and specific in diagnosing malaria among returned travellers in Bergen, Norway. (ekstern lenke)
• Siri Kratter Abrahamsen; Cathrine Ingebjørg Nødtvedt Haugen; Priscilla Rupali et al. (2013). Fever in the tropics: aetiology and case-fatality - a prospective observational study in a tertiary care hospital in South India. (ekstern lenke)
• Kurt Hanevik; Einar Klæboe Kristoffersen; Steinar Sørnes et al. (2012). Immunophenotyping in post-giardiasis functional gastrointestinal disease and chronic fatigue syndrome. (ekstern lenke)
• Knut-Arne Wensaas; Nina Langeland; Kurt Hanevik et al. (2012). Irritable bowel syndrome and chronic fatigue 3 years after acute giardiasis: historic cohort study. (ekstern lenke)
• Karolina Rembeck; Åsa Alsiö; Peer Brehm Christensen et al. (2012). Impact of IL28B-related single nucleotide polymorphisms on liver histopathology in chronic hepatitis C genotype 2 and 3. (ekstern lenke)
• Åsa Alsiö; Anna-Maria Jannesson; Nina Langeland et al. (2012). Early quantification of HCV core antigen may help to determine the duration of therapy for chronic genotype 2 or 3 HCV infection. (ekstern lenke)
• Åsa Alsiö; Karolina Rembeck; Galia Askarieh et al. (2012). Impact of Obesity on the Bioavailability of Peginterferon-alpha 2a and Ribavirin and Treatment Outcome for Chronic Hepatitis C Genotype 2 or 3. (ekstern lenke)
• Karolina Rembeck; Cristina Maglio; Martin Lagging et al. (2012). PNPLA 3 I148M genetic variant associates with insulin resistance and baseline viral load in HCV genotype 2 but not in genotype 3 infection. (ekstern lenke)
• Gunnhild Sellevoll Hunskår; Nina Langeland; Knut-Arne Wensaas et al. (2012). The impact of atopic disease on the risk of post-infectious fatigue and irritable bowel syndrome 3 years after Giardia infection. A historic cohort study. (ekstern lenke)
• Thomas Zoller; Thomas Junghanss; Annette Kapaun et al. (2011). Intravenous Artesunate for Severe Malaria in Travelers, Europe. (ekstern lenke)
• Magnus Lindh; Martin Lagging; Martti Färkkilä et al. (2011). Interleukin 28B gene variation at rs12979860 determines early viral kinetics during treatment in patients carrying genotypes 2 or 3 of hepatitis C virus. (ekstern lenke)
• Court Pedersen; Åsa Alsiö; Martin Lagging et al. (2011). Ribavirin plasma concentration is a predictor of sustained virological response in patients treated for chronic hepatitis C virus genotype 2/3 infection. (ekstern lenke)
• Maria Lindh; Anders Eilard; Martti Färkkilä et al. (2011). Hepatitis C treatment response kinetics and impact of baseline predictors. (ekstern lenke)
• Lucy J Robertson; K Hanevik; Angel A Escobedo et al. (2010). Giardiasis ? why do the symptoms sometimes never stop?. (ekstern lenke)
• Åsa Alsiö; Peer Brehm Christensen; Martti Färkkilä et al. (2010). Nonresponder Patients with Hepatitis C Virus Genotype 2/3 Infection: A Question of Low Systemic Interferon Concentrations?. (ekstern lenke)
• Peter Derek Christian Leutscher; Martin Lagging; Mads Rauning Buhl et al. (2010). Evaluation of depression as a risk factor for treatment failure in chronic hepatitis C. (ekstern lenke)
• Angel A Escobedo; P Almirall; Lucy J Robertson et al. (2010). Giardiasis: the ever-present threat of a neglected disease. (ekstern lenke)
• Kristine Mørch; Kurt Hanevik; Guri Rørtveit et al. (2009). High rate of fatigue and abdominal symptoms 2 years after an outbreak of giardiasis. (ekstern lenke)
• Kristine Mørch; Kurt Hanevik; Guri Rørtveit et al. (2009). Severity of Giardia infection associated with post-infectious fatigue and abdominal symptoms two years after. (ekstern lenke)
• Elisabeth Astrup Strand; Lucy J. Robertson; Kurt Hanevik et al. (2008). Sensitivity of a Giardia antigen test in persistent giardiasis following an extensive outbreak. (ekstern lenke)
• Kurt Hanevik; Kristine Mørch; Geir Egil Eide et al. (2008). Effects of albendazole/metronidazole or tetracycline/folate treatments on persisting symptoms after Giardia infection: A randomized open clinical trial. (ekstern lenke)
• Martin Lagging; Nina Langeland; Court Pedersen et al. (2008). Randomized comparison of 12 or 24 weeks of peginterferon alpha-2a and ribavirin in chronic hepatitis C virus genotype 2/3 infection. (ekstern lenke)
• Kristine Mørch; Kurt Hanevik; Lucy J. Robertson et al. (2008). Treatment-ladder and genetic characterisation of parasites in refractory giardiasis after an outbreak in Norway. (ekstern lenke)

Vitenskapelig litteraturgjennomgang

• Lucy J Robertson; Kurt Hanevik; Angel A. Escobedo et al. (2010). Giardiasis - why do the symptoms sometimes never stop?. (ekstern lenke)

Se en fullstendig oversikt over publikasjoner i NVA.